Membrane proteomic signatures of karyotypically normal and abnormal human embryonic stem cell lines and derivatives

Proteomics

Volumn 11, Issue 12, 2011, Pages 2515-2527

  Gerwe, Brian A ^a,b   Angel, Peggi M ^c   West, Franklin D ^a   Hasneen, Kowser ^a   Young, Amber ^b   Orlando, Ron ^c   Stice, Steven L ^a,b  

^a University of Georgia ^*  (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell biology; Flow cytometry; Human embryonic stem cells; Membrane proteomics

Indexed keywords

AQUAPORIN; BETA6 INTEGRIN; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA; CONTACTIN; DIPEPTIDYL PEPTIDASE I; DYSFERLIN; DYSTROGLYCAN; EPHRIN B2; GALECTIN 3; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; JUNCTIONAL ADHESION MOLECULE A; MEMBRANE PROTEIN; NECTIN 1; PLEXIN; SOMATOMEDIN C RECEPTOR; SUCROSE; SYNAPTOTAGMIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL EXPANSION; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ION TRAP MASS SPECTROMETRY; KARYOTYPE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; X CHROMOSOME;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CHROMATOGRAPHY, REVERSE-PHASE; CHROMOSOME DUPLICATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; KARYOTYPING; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; NEURAL STEM CELLS; PEPTIDE FRAGMENTS; PROTEOMICS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRISOMY; TRYPSIN;

EID: 79958093457     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000032     Document Type: Article

References (62)

1. Shevinsky, L. H., Knowles, B. B., Damjanov, I., Solter, D., Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982, 30, 697-705.
2. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A. et al., Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
3. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M. et al., Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 2007, 25, 803-816.
4. Abeyta, M. J., Clark, A. T., Rodriguez, R. T., Bodnar, M. S. et al., Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum. Mol. Genet. 2004, 13, 601-608.
5. Laslett, A., Grimmond, S., Gardiner, B., Stamp, L. et al., Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev. Biol. 2007, 7, 12.
6. Herszfeld, D., Wolvetang, E., Langton-Bunker, E., Chung, T. L. et al., CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat. Biotechnol. 2006, 24, 351-357.
7. Denning, C., Allegrucci, C., Priddle, H., Barbadillo-Munoz, M. D. et al., Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int. J. Dev. Biol. 2006, 50, 27-37.
8. Tavakoli, T., Xiangru, X., Derby, E., Yevgeniya, S. et al., Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V. BMC Cell Biol. 2009, 10, 44.
9. Draper, J. S., Smith, K., Gokhale, P., Moore, H. D. et al., Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004, 22, 53-54.
10. Zeng, X., Chen, J., Liu, Y., Luo, Y. et al., BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. Restor. Neurol. Neurosci. 2004, 22, 421-428.
11. Cowan, C. A., Klimanskaya, I., McMahon, J., Atienza, J. et al., Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 2004, 350, 1353-1356.
12. Mitalipova, M. M., Rao, R. R., Hoyer, D. M., Johnson, J. A. et al., Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 2005, 23, 19-20.
13. Yang, S., Lin, G., Tan, Y. Q., Deng, L. Y. et al., Differences between karyotypically normal and abnormal human embryonic stem cells. Cell Prolif. 2010, 43, 195-206.
14. Weiss, S., Reynolds, B. A., Vescovi, A. L., Morshead, C. et al., Is there a neural stem cell in the mammalian forebrain? Trends Neurosci. 1996, 19, 387-393.
15. Shin, S., Mitalipova, M., Noggle, S., Tibbitts, D. et al., Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 2006, 24, 125-138.
16. Shin, S., Dalton, S., Stice, S. L., Human motor neuron differentiation from human embryonic stem cells. Stem Cell. Dev. 2005, 14, 266-269.
17. Carpenter, M. K., Inokuma, M. S., Denham, J., Mujtaba, T. et al., Enrichment of neurons and neural precursors from human embryonic stem cells. Exp. Neurol. 2001, 172, 383-397.
18. Rao, R. R., Stice, S. L., Gene expression profiling of embryonic stem cells leads to greater understanding of pluripotency and early developmental events. Biol. Reprod. 2004, 71, 1772-1778.
19. Hong, S., Kang, U. J., Isacson, O., Kim, K. S., Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons. J. Neurochem. 2008, 104, 316-324.
20. Peh, G. S., Lang, R., Pera, M., Hawes, S., CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation. Stem Cell Dev 2009, 18, 269-282.
21. Harkness, L., Christiansen, H., Nehlin, J., Barington, T. et al., Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions. Stem Cell Res. 2008, 1, 219-227.
22. Dormeyer, W., van Hoof, D., Braam, S. R., Heck, A. J. et al., Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J. Proteome Res. 2008, 7, 2936-2951.
23. Prokhorova, T. A., Rigbolt, K. T. G., Johansen, P. T., Henningsen, J. et al., Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol. Cell. Proteomics 2009, 8, 959.
24. Van Hoof, D., Dormeyer, W., Braam, S. R., Passier, R. et al., Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J. Proteome Res. 2010, 9, 1610-1618.
25. Mitalipova, M., Calhoun, J., Shin, S. J., Wininger, D. et al., Human embryonic stem cell lines derived from discarded embryos. Stem Cells 2003, 21, 521-526.
26. Boyd, N. L., Dhara, S. K., Rekaya, R., Godbey, E. A. et al., BMP4 promotes formation of primitive vascular networks in human embryonic stem cell-derived embryoid bodies. Exp. Biol. Med. (Maywood) 2007, 232, 833-843.
27. Mumaw, J. L., Machacek, D., Shields, J. P., Dodla, M. C. et al., Neural differentiation of human embryonic stem cells at the ultrastructural level. Microsc. Microanal. 2010, 16, 80-90.
28. Simpson, R. J., Connolly, L. M., Eddes, J. S., Pereira, J. J. et al., Proteomic analysis of the human colon carcinoma cell line (LIM 1215): development of a membrane protein database. Electrophoresis 2000, 21, 1707-1732.
29. Wu, C. C., MacCoss, M. J., Howell, K. E., Yates, J. R., 3rd, A method for the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 2003, 21, 532-538.
30. Miguet, L., Pacaud, K., Felden, C., Hugel, B. et al., Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2006, 6, 153-171.
31. Seyfried, N. T., Huysentruyt, L. C., Atwood, J. A., 3rd, Xia, Q. et al., Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett. 2008, 263, 243-252.
32. Pedrioli, P. G., Eng, J. K., Hubley, R., Vogelzang, M. et al., A common open representation of mass spectrometry data and its application to proteomics research. Nat. Biotechnol. 2004, 22, 1459-1466.
33. Perkins, D. N., Pappin, D. J. C., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
34. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
35. Weatherly, D. B., Atwood, J. A., Minning, T. A., Cavola, C. et al., A heuristic method for assigning a false-discovery rate for protein identifications from mascot database search results. Mol. Cell. Proteomics 2005, 4, 762-772.
36. Choi, H., Nesvizhskii, A. I., Semisupervised model-based validation of peptide identifications in mass spectrometry-based proteomics. J. Proteome Res. 2008, 7, 254-265.
37. Horton, P., Park, K. J., Obayashi, T., Fujita, N. et al., WoLF PSORT: protein localization predictor. Nucleic Acids Res. 2007, 35, W585-W587.
38. Krogh, A., Larsson, B., von Heijne, G., Sonnhammer, E. L. L., Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. J. Mol. Biol. 2001, 305, 567-580.
39. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene Ontology: tool for the unification of biology. Nat. Genet. 2000, 25, 25-29.
40. Zhang, B., Kirov, S., Snoddy, J., WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33, W741.
41. McQuade, L. R., Schmidt, U., Pascovici, D., Stojanov, T., Baker, M. S., Improved membrane proteomics coverage of human embryonic stem cells by peptide IPG-IEF. J. Proteome Res. 2009, 8, 5642-5649.
42. Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A. et al., Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 1997, 278, 477-483.
43. Wang, H. Y., Malbon, C. C., Wnt-frizzled signaling to G-protein-coupled effectors. Cell. Mol. Life Sci. 2004, 61, 69-75.
44. Melchior, K., Weiss, J., Zaehres, H., Kim, Y. M. et al., The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells. Biol. Chem. 2008, 389, 897-903.
45. Yamamoto, K., Korenaga, R., Kamiya, A., Qi, Z. et al., P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H285-H292.
46. Glass, R., Loesch, A., Bodin, P., Burnstock, G., P2X(4) and P2X(6) receptors associate with VE-cadherin in human endothelial cells. Cell. Mol. Life Sci. 2002, 59, 870-881.
47. Solecki, D. J., Gromeier, M., Mueller, S., Bernhardt, G., Wimmer, E., Expression of the human poliovirus receptor/CD155 gene is activated by sonic hedgehog. J. Biol. Chem. 2002, 277, 25697-25702.
48. Oda, T., Ohka, S., Nomoto, A., Ligand stimulation of CD155[alpha] inhibits cell adhesion and enhances cell migration in fibroblasts. Biochem. Biophys. Res. Commun. 2004, 319, 1253-1264.
49. Fraering, P. C., Ye, W., Strub, J.-M., Dolios, G. et al., Purification and characterization of the human gamma-secretase complex. Biochemistry 2004, 43, 9774-9789.
50. Lee, S.-F., Shah, S., Li, H., Yu, C. et al., Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and notch. J. Biol. Chem. 2002, 277, 45013-45019.
51. Robinson, J. M., Ackerman Iv, W. E., Behrendt, N. J., Vandre, D. D., While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems. Biol. Reprod. 2009, 81, 33-39.
52. Davis, D. B., Doherty, K. R., Delmonte, A. J., McNally, E. M., Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J. Biol. Chem. 2002, 277, 22883-22888.
53. Liu, J., Aoki, M., Illa, I., Wu, C. et al., Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 1998, 20, 31-36.
54. Vainzof, M., Ayub-Guerrieri, D., Onofre, P. C. G., Martins, P. C. M. et al., Animal models for genetic neuromuscular diseases. J. Mol. Neurosci. 2008, 34, 241-248.
55. Bonnemann, C. G., Finkel, R. S., Sarcolemann proteins and the spectrum of limb-girdle muscular dystrophies. Semin. Pediatr. Neurol. 2002, 9, 81-99.
56. DeChiara, T. M., Vejsada, R., Poueymirou, W. T., Acheson, A. et al., Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995, 83, 313-322.
57. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M. et al., Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374, 1.
58. Panayotatos, N., Radziejewska, E., Acheson, A., Somogyi, R. et al., Localization of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J. Biol. Chem. 1995, 270, 14007.
59. Shimazaki, T., Shingo, T., Weiss, S., The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells. J. Neurosci. 2001, 21, 7642-7653.
60. Sugano, Y., Takeuchi, M., Hirata, A., Matsushita, H. et al., Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells. Blood 2008, 111, 1167-1172.
61. Palmeri, D., van Zante, A., Huang, C. C., Hemmerich, S., Rosen, S. D., Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J. Biol. Chem. 2000, 275, 19139-19145.
62. Malergue, F., Galland, F., Martin, F., Mansuelle, P. et al., A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol. Immunol. 1998, 35, 1111-1119.